Collagen implant for severe corneal melting
Part of Eyes & vision clinical trials.
This study tests whether a collagen implant can help heal a severely damaged cornea (the clear front part of the eye) when standard treatments haven't worked. It may offer a new option to stop the cornea from breaking down further.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with severe corneal melting (the cornea is thinning or developing holes).
- Standard treatments like antibiotic/antiviral drops, anti-inflammatory drops, lubricants, or contact lenses haven't stopped the melting or it is getting worse.
- You have not had an active eye infection at the time of screening.
- You are not pregnant or breastfeeding.
- You are willing to give written informed consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies collagen cross-linking, a procedure meant to strengthen a weakened cornea in people with keratoconus. It may help slow the bulging/weakening of the cornea and improve vision, and the study also uses special imaging to check changes over time.
This study tests whether a collagen shield (a small protective lens) placed on the eye helps heal a corneal abrasion (a scratch on the clear surface of the eye) better than standard treatment in the emergency department. It may help reduce pain and speed healing.
This study tests a new hydrogel glue that helps heal a damaged cornea (the clear front part of the eye) without needing stitches. It may help people with certain corneal defects from injury or after surgery.
This trial tests a treatment called corneal collagen crosslinking to strengthen the tissue under a KPro type I (an artificial cornea). It may help reduce the risk of corneal melting in people who need a KPro.
This Phase 2 trial tests a locally delivered cell-based treatment (allogeneic mesenchymal stromal cells) to help heal long-lasting damage to the eye’s clear surface (the cornea). It may help if your cornea epithelium (surface layer) won’t improve even after standard non-surgical treatments.
This Phase 2 study tests how safe and well a corneal cross-linking device (called PXL-Platinum 330) works for people with corneal ectasia (a thinning/steepening of the cornea). If you qualify, the goal is to help stop or slow further worsening of your cornea shape and improve eye stability.
Hear when a new Patients With Severe Corneal Melting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.